| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A century past the discovery of insulin: global progress and challenges for type 1 diabetes among children and adolescents in low-income and middle-income countries
|
Bhutta, Zulfiqar A
|
|
|
398 |
10313 |
p. 1837-1850
|
article
|
| 2 |
A pruritic psoriatic plaque develops at the donor site of an autologous skin graft: Koebner phenomenon
|
Murphy, Michael J
|
|
|
398 |
10313 |
p. 1836
|
article
|
| 3 |
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
|
Nazarzadeh, Milad
|
|
|
398 |
10313 |
p. 1803-1810
|
article
|
| 4 |
Blood pressure lowering in the prevention of type 2 diabetes
|
Cavender, Matthew A
|
|
|
398 |
10313 |
p. 1778-1779
|
article
|
| 5 |
By any means necessary: why lowering insulin prices is relevant to racial health equity
|
Peek, Monica E
|
|
|
398 |
10313 |
p. 1783-1784
|
article
|
| 6 |
Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland
|
Grange, Zoe
|
|
|
398 |
10313 |
p. 1799-1800
|
article
|
| 7 |
Cold comfort: getting insulin to those who need it
|
Devi, Sharmila
|
|
|
398 |
10313 |
p. 1791
|
article
|
| 8 |
Department of Error
|
|
|
|
398 |
10313 |
p. 1802
|
article
|
| 9 |
Insulin's centenary: complexity and collaboration
|
Li, Alison
|
|
|
398 |
10313 |
p. 1796-1797
|
article
|
| 10 |
Insulin, the patient, and the health professional
|
Heller, Simon R
|
|
|
398 |
10313 |
p. 1785-1786
|
article
|
| 11 |
Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine?
|
Pavord, Sue
|
|
|
398 |
10313 |
p. 1801
|
article
|
| 12 |
Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? – Authors’ reply
|
Bhuyan, Prakash
|
|
|
398 |
10313 |
p. 1801-1802
|
article
|
| 13 |
Monica Peek: addressing diabetes health disparities
|
Samarasekera, Udani
|
|
|
398 |
10313 |
p. 1792
|
article
|
| 14 |
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
|
Sonabend, Raphael
|
|
|
398 |
10313 |
p. 1825-1835
|
article
|
| 15 |
Nowcasting towards sustainable SARS-CoV-2 endemicity
|
Leung, Gabriel M
|
|
|
398 |
10313 |
p. 1781-1783
|
article
|
| 16 |
Offline: Decolonisation and the demand for a just memory
|
Horton, Richard
|
|
|
398 |
10313 |
p. 1787
|
article
|
| 17 |
Origins of the insulin crisis: how a century of price-fixing controversies affects the cost of care today
|
Strodel, Rachel J
|
|
|
398 |
10313 |
p. 1793-1795
|
article
|
| 18 |
Restoring biodiversity and slowing climate change are crucial to protect health
|
Butler, Colin D
|
|
|
398 |
10313 |
p. 1802
|
article
|
| 19 |
Stephen Warren
|
Green, Andrew
|
|
|
398 |
10313 |
p. 1798
|
article
|
| 20 |
Sudan coup prompts fresh health and humanitarian fears
|
Devi, Sharmila
|
|
|
398 |
10313 |
p. 1790
|
article
|
| 21 |
Surpassing insulin glargine in type 2 diabetes with tirzepatide
|
Khoo, Bernard
|
|
|
398 |
10313 |
p. 1779-1781
|
article
|
| 22 |
The Global Drug Policy Index: tracking national drug policies
|
Thornton, Jacqui
|
|
|
398 |
10313 |
p. 1788-1789
|
article
|
| 23 |
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
|
Del Prato, Stefano
|
|
|
398 |
10313 |
p. 1811-1824
|
article
|
| 24 |
100 years of insulin: a technical success but an access failure
|
The Lancet,
|
|
|
398 |
10313 |
p. 1777
|
article
|
Journal description